SCHEMBL1164804

SCHEMBL1164804

CN(Cc1ccccc1)/N=C/c1ccc(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.53
▸ KMT2A Q03164 8/20 0.53
▸ MAPT P10636 5/20 0.53
▸ LMNA P02545 4/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ GAA P10253 3/20 0.52
▸ G6PC1 P35575 5/20 0.50
▸ BCHE P06276 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ ALPL P05186 1/20 0.46
▸ ALPI P09923 1/20 0.46
▸ ALPG P10696 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1164805 1.00 MEN1 (0.53) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL12506255 0.77 ACHE (0.41) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL15439114 0.77 G6PC1 (0.55) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL1132163 0.77 MEN1 (0.72) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL11938814 0.77 G6PC1 (0.55) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL15439112 0.77 G6PC1 (0.55) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL1132161 0.77 MEN1 (0.72) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL15440153 0.77 G6PC1 (0.50) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL15440151 0.77 G6PC1 (0.50) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL11266387 0.73 G6PC1 (0.58) MEN1KMT2AMAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512066-B2 Enhancers of protein degradation MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2016-12-06 — — US claimed
US-20120282629-A1 Enhancers of Protein Degradation MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2012-11-08 — — US claimed
EP-2488485-A1 ENHANCERS OF PROTEIN DEGRADATION Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-08-22 — — EP claimed
US-9512066-B2 Enhancers of protein degradation MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2016-12-06 — — US disclosed
US-20120282629-A1 Enhancers of Protein Degradation MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2012-11-08 — — US disclosed
EP-2488485-A1 ENHANCERS OF PROTEIN DEGRADATION Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-08-22 — — EP disclosed
WO-2011020883-A9 ENHANCERS OF PROTEIN DEGRADATION Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-07-12 — — WO disclosed
WO-2011020883-A1 ENHANCERS OF PROTEIN DEGRADATION Max-Delbrück-Centrum für Molekulare Medizin (DE) 2011-02-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120282629-A1 Enhancers of Protein Degradation HTT, HYPK, TFEB MEN1 3413/4885KMT2A 2000/4885MAPT 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback